Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia
Blinatumomab 再次治疗复发/难治性 B 前体急性淋巴细胞白血病患者
期刊:Leukemia
影响因子:13.4
doi:10.1038/leu.2017.306
Topp, M S; Stelljes, M; Zugmaier, G; Barnette, P; Heffner, L T Jr; Trippett, T; Duell, J; Bargou, R C; Holland, C; Benjamin, J E; Klinger, M; Litzow, M R